shutterstock_411455971.jpg
 


Raising Awareness and Reducing Risks of Psychedelics through Education, Psychotherapy, and Community

 

Why Us?

The Psychedelic Education and Continuing Care Program is designed to assist people who have had psychedelic experiences and are seeking support in connection with those experiences, as well as people who would like to learn more about psychedelics. Our overarching intention for the program is to increase awareness and reduce risks of psychedelic use. We see this as a natural extension of the harm reduction approach that the Center for Optimal Living is known for.

Individuals who have had difficult experiences can benefit from a better understanding of the often-challenging feelings stirred up by psychedelics. Those who have had positive experiences can use supportive therapy to bolster and integrate these insights into their daily lives.

 

 

 

 
 

While the use of psychedelic substances remains tightly controlled in the United States, the reality is that many individuals continue to make use of these substances in a variety of settings and contexts; many of them less than optimal. Despite the potential benefits psychedelics have to offer, there are real risks associated with their unsupervised use. For some users, the effect of psychedelics can make even ordinary, familiar experiences overwhelming, particularly when experienced alone or in less controlled settings like music festivals. Other users remain confused or anxious long after their experience is over or have difficulty processing the conflicting thoughts and feelings that such experiences often bring to the surface.

Previously, individuals seeking support for psychedelic experiences, or simply looking to better understand and make use of the insights they had gained had few options for professional support. The Psychedelic Education and Continuing Care Program is tailored to meet people with full engagement and open curiosity, and to aid those who seek support in navigating their relationship with these substances.

 
 

WHAT WE OFFER

*DISCLAIMER: The Psychedelic Education and Continuing Care Program does not provide psychoactive or illicit substances. We do not conduct or promote psychedelic psychotherapy outside of approved clinical trials and we do not provide referrals to “underground” (illegal) psychedelic services.

 
 
shutterstock_588801860.jpg

Individual Psychotherapy

Are you looking for a psychotherapist who has a professional understanding of psychedelics and their use? We provide individual treatment tailored to your needs. This can include support in integrating psychedelic experiences, but may also extend to other areas of a person’s life. We will also help individuals explore and clarify their desire and motivation to continue to use psychedelics, or reduce their use.

 
storm-sky.jpg

Group Psychotherapy

Group psychotherapy sessions utilize interpersonal connections with other group members who have a relationship to psychedelics. Some group members have had their own experiences, while others are learning about whether psychedelics will play a role in their lives. Group discussions focus on integrating insights, lessons, and even challenging experiences with psychedelics into one's broader life. 

 
shutterstock_451784422.jpg

Evaluation and Consultation

Have you wondered whether they may be risks associated with using psychedelics? We can conduct comprehensive evaluations, to assess for potential risk factors and assessment of individuals who are having difficult experiences related to psychedelic use.

 

UPCOMING TRAINING & WORKSHOPS

Psychedelic Education and Continuing Care Program is hosting its second Psychedelic Integration Training for Clinicians event this September. This time it will be a two day event, so we can cover even more ground. Single day tickets are also available! We are offering an early bird discount as well as student pricing. Ingmar Gorman Ph.D., Elizabeth Nielson Ph.D., and Andrew Tatarsky Ph.D. will be speaking.

This 2-day training offered by psychologists Ingmar Gorman PhD and Elizabeth Nielson PhD is designed for clinicians and healthcare providers who want to learn more about current psychedelic research and clinical practice, including how to work with patients who have a history of psychedelic use or have expressed an interest in using psychedelics. Sign up for either or both days (recommended).

Psychedelics 101: Your patients are curious and so are you: What is all this about psychedelics being used for treatment of addiction and trauma? This session gives an overview of psychedelic drugs, their history, and current research with MDMA and Psilocybin-assisted therapy. This program includes overview of recent and current clinical trials, outcomes, legal status, and what it all means for the future of addiction and trauma treatment.

Objectives: Participants will be able to articulate the justifications for psychedelic clinical research, answer clients’ basic questions about the state of psychedelic clinical research, rescheduling efforts, and how psychedelic-assisted psychotherapy works.

Psychedelics 102: What is psychedelic harm reduction and integration and how can they occur in a clinical setting? This session focuses on translating research findings into clinical practice including working with patients who are considering using psychedelics, actually using psychedelics, or have used them. This program includes discussion of assessment and integration techniques, resources, and legal and ethical issues.

Objectives: Participants will be able to engage in basic psychedelic harm reduction (safety planning) with clients, define and differentiate psychedelic integration psychotherapy, and identify key “red flags” that indicate someone should seek specialized psychiatric care after a psychedelic experience.

Full program cost: $400 | Single day cost: $200

Early-Bird: Register before 8/25/18 and receive 25% discount

Student Price (Limited number of tickets): $100

*For student discount, email us at info@psychedelicprogram.com with your school's .edu address and we will provide your discount code.

 
https_%2F%2Fcdn.evbuc.com%2Fimages%2F44974596%2F61904576799%2F1%2Foriginal.jpg

 Our Psychedelic Harm Reduction and Integration Psychotherapy (PHRIP) Supervision group is a 12-session weekly group meeting for clinicians who have taken our Psychedelics 101 & 102 for Clinicians intensive training or have similar background knowledge. The first group meeting will focus on introductions, format, and an overview of our approach. Subsequent group meeting will commence with the introduction of a specific theory, principal, or topic, followed by a case vignette presented by a group member and discussion. The final group meeting will focus on transitioning to working independently and continued professional development opportunities. Each group participant will have the opportunity to present 1-2 cases through the course of the program.

All participants should be independently licensed psychologists, social workers, psychiatrists, or other mental health care providers. This program does not provide supervised hours towards licensure of any kind. Graduate students, trainees, and those working towards licensure under another supervisor will be considered on a case-by-case basis. Admission to the program is rolling and will continue until the group is filled. INTERESTED PARTICIPANTS SHOULD FILL OUT THIS APPLICATION. Applicants will be notified of admission status within 14 days of applying, and have 14 days after notification to remit payment to secure a spot in the program. Space is limited to 10 participants. Group sessions will be lead by either Elizabeth Nielson or Ingmar Gorman on alternating weeks, with both leaders present at the first and last sessions.

2018 Fall Program Dates (Thursdays, 12:00-1:15PM):

September 13, 20, 27,
October 11, 18, 25,
November 1, 8, 15, 29
December 6, 13 (Snow date December 20)

Program Cost: $1200

Media